Repare Book Value Per Share from 2010 to 2024

RPTX Stock

USD 2.81 0.16 5.39%

Repare Therapeutics Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share will likely drop to 3.26 in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Repare Therapeutics according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

5.03837987

Current Value

3.26

Quarterly Volatility

3.78808059

Credit Downgrade

Yuan Drop

Covid

Check Repare Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Repare Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 2.8 M, Interest Income of 13.8 M or Depreciation And Amortization of 1.8 M, as well as many indicators such as Price To Sales Ratio of 5.71, Dividend Yield of 0.0 or PTB Ratio of 1.52. Repare financial statements analysis is a perfect complement when working with Repare Therapeutics Valuation or Volatility modules.

Check out the analysis of Repare Therapeutics Correlation against competitors.

For more information on how to buy Repare Stock please use our How to Invest in Repare Therapeutics guide.

Latest Repare Therapeutics' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Repare Therapeutics over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Repare Therapeutics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Repare Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 4.12 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Repare Book Value Per Share Regression Statistics

	Arithmetic Mean	1.09
	Geometric Mean	2.25
	Coefficient Of Variation	347.55
	Mean Deviation	3.32
	Median	(1.42)
	Standard Deviation	3.79
	Sample Variance	14.35
	Range	9.1901
	R-Value	0.74
	Mean Square Error	6.95
	R-Squared	0.55
	Significance	0
	Slope	0.63
	Total Sum of Squares	200.89

Repare Book Value Per Share History

	2024	3.26
	2023	5.04
	2022	6.67
	2021	7.63
	2020	7.77
	2019	-1.26

Other Fundumenentals of Repare Therapeutics

Tangible Book Value Per Share

Repare Therapeutics Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Debt	Short Term Investments
Total Assets		0.98	0.95	-0.91	-0.82	0.47	0.61	0.86	0.49	0.98	1.0	0.96	0.99	0.96	0.9	0.65	0.83	0.6
Total Stockholder Equity	0.98		0.98	-0.88	-0.82	0.42	0.61	0.84	0.31	1.0	0.98	0.98	0.97	0.98	0.9	0.63	0.84	0.61
Net Tangible Assets	0.95	0.98		-0.83	-0.86	0.47	0.67	0.87	0.26	0.98	0.95	0.99	0.94	0.99	0.94	0.6	0.89	0.64
Net Debt	-0.91	-0.88	-0.83		0.56	-0.6	-0.37	-0.62	-0.51	-0.88	-0.91	-0.81	-0.94	-0.81	-0.7	-0.34	-0.57	-0.22
Retained Earnings	-0.82	-0.82	-0.86	0.56		-0.45	-0.89	-0.99	-0.27	-0.82	-0.81	-0.9	-0.78	-0.9	-0.87	-0.64	-0.96	-0.77
Accounts Payable	0.47	0.42	0.47	-0.6	-0.45		0.58	0.44	0.39	0.42	0.46	0.44	0.52	0.44	0.44	-0.29	0.31	-0.14
Net Receivables	0.61	0.61	0.67	-0.37	-0.89	0.58		0.82	0.16	0.61	0.61	0.69	0.6	0.69	0.76	0.33	0.75	0.59
Capital Surpluse	0.86	0.84	0.87	-0.62	-0.99	0.44	0.82		0.34	0.84	0.85	0.91	0.82	0.91	0.85	0.68	0.96	0.75
Total Liab	0.49	0.31	0.26	-0.51	-0.27	0.39	0.16	0.34		0.31	0.49	0.31	0.5	0.31	0.36	0.31	0.24	0.2
Net Invested Capital	0.98	1.0	0.98	-0.88	-0.82	0.42	0.61	0.84	0.31		0.98	0.98	0.97	0.98	0.9	0.63	0.84	0.61
Total Current Assets	1.0	0.98	0.95	-0.91	-0.81	0.46	0.61	0.85	0.49	0.98		0.96	0.99	0.96	0.9	0.65	0.83	0.61
Capital Stock	0.96	0.98	0.99	-0.81	-0.9	0.44	0.69	0.91	0.31	0.98	0.96		0.94	1.0	0.94	0.66	0.93	0.69
Net Working Capital	0.99	0.97	0.94	-0.94	-0.78	0.52	0.6	0.82	0.5	0.97	0.99	0.94		0.94	0.88	0.57	0.78	0.53
Common Stock	0.96	0.98	0.99	-0.81	-0.9	0.44	0.69	0.91	0.31	0.98	0.96	1.0	0.94		0.94	0.66	0.93	0.69
Property Plant Equipment	0.9	0.9	0.94	-0.7	-0.87	0.44	0.76	0.85	0.36	0.9	0.9	0.94	0.88	0.94		0.64	0.89	0.76
Current Deferred Revenue	0.65	0.63	0.6	-0.34	-0.64	-0.29	0.33	0.68	0.31	0.63	0.65	0.66	0.57	0.66	0.64		0.74	0.91
Short Term Debt	0.83	0.84	0.89	-0.57	-0.96	0.31	0.75	0.96	0.24	0.84	0.83	0.93	0.78	0.93	0.89	0.74		0.83
Short Term Investments	0.6	0.61	0.64	-0.22	-0.77	-0.14	0.59	0.75	0.2	0.61	0.61	0.69	0.53	0.69	0.76	0.91	0.83

Click cells to compare fundamentals

About Repare Therapeutics Financial Statements

Repare Therapeutics investors use historical fundamental indicators, such as Repare Therapeutics' Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Repare Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	5.04	3.26
Tangible Book Value Per Share	5.04	3.26

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Repare Stock Analysis

When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC